Silence Therapeutics (SLN) Stock Highlights

4.79 | -4.2%

2025-02-22 06:38:54

Silence Therapeutics PLC is one of the leading companies in the ribonucleic acid (RNA) technology field. The United Kingdom-based firm focused on discovering and developing novel molecules incorporating short interfering ribonucleic acid, or siRNA, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical needs. Its income consists of royalty income and revenue from collaboration agreements. Its geographical segments are the United Kingdom, the United States, and Germany.

Statistics

Range Today

4.75 5.1

Volume Today 137.3K

Range 1 Year

4.06 27.72

Volume 1 Year 73.18M

Range 3 Year

4.06 27.72

Volume 3 Year 106.61M

Range 10 Year

4.06 35

Volume 10 Year 110.15M

Highlights

Market Capitalization 226.16M (small)

Floating Shares 77.51M

Current Price 4.79

Price To Earnings -2.94

Price To Revenue 33.83

Price To Book 2.39

Earnings Per Share -1.69

Payout Ratio 0%

Performance

Latest -4.2%

1 Month -8.94%

3 Months -30.28%

6 Months -70.34%

1 Year -80.42%

3 Years -74.45%

5 Years -75.44%

10 Years -75.44%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.